Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Osteoporosis

  Free Subscription


Articles published in J Bone Miner Res

Retrieve available abstracts of 230 articles:
HTML format
Text format



Single Articles


    November 2019
  1. OCHS-BALCOM HM, Hovey KM, Andrews C, Cauley JA, et al
    Short Sleep Is Associated With Low Bone Mineral Density and Osteoporosis in the Women's Health Initiative.
    J Bone Miner Res. 2019 Nov 6. doi: 10.1002/jbmr.3879.
    PubMed     Text format     Abstract available


  2. CHU L, Liu X, He Z, Han X, et al
    Articular cartilage degradation and aberrant subchondral bone remodeling in patients with osteoarthritis and osteoporosis.
    J Bone Miner Res. 2019 Nov 6. doi: 10.1002/jbmr.3909.
    PubMed     Text format     Abstract available


  3. JIN H, Ma X, Liu Y, Yin X, et al
    Back Pain-Inducing Test, a novel and sensitive screening test for painful osteoporotic vertebral fractures: A prospective clinical study.
    J Bone Miner Res. 2019 Nov 6. doi: 10.1002/jbmr.3912.
    PubMed     Text format     Abstract available


  4. WONG AK, Chandrakumar A, Whyte R, Reitsma S, et al
    Bone Marrow and Muscle Fat Infiltration are Correlated Among Postmenopausal Women with Osteoporosis: the AMBERS Cohort Study.
    J Bone Miner Res. 2019 Nov 1. doi: 10.1002/jbmr.3910.
    PubMed     Text format     Abstract available


    October 2019
  5. WOODS GN, Ewing SK, Sigurdsson S, Kado DM, et al
    Greater Bone Marrow Adiposity Predicts Bone Loss in Older Women.
    J Bone Miner Res. 2019 Oct 16. doi: 10.1002/jbmr.3895.
    PubMed     Text format     Abstract available


  6. SUN M, Hu L, Wang S, Huang T, et al
    Circulating MicroRNA-19b Identified from Osteoporotic Vertebral Compression Fracture Patients Increases Bone Formation.
    J Bone Miner Res. 2019 Oct 15. doi: 10.1002/jbmr.3892.
    PubMed     Text format     Abstract available


  7. PINEDA-MONCUSI M, Garcia-Giralt N, Diez-Perez A, Servitja S, et al
    Increased Fracture Risk in Women Treated with Aromatase Inhibitors versus Tamoxifen: Beneficial Effect of Bisphosphonates.
    J Bone Miner Res. 2019 Oct 9. doi: 10.1002/jbmr.3886.
    PubMed     Text format     Abstract available


  8. NYSTROM A, Kiritopoulos D, Ullmark G, Sorensen J, et al
    Denosumab Prevents Early Periprosthetic Bone Loss after Uncemented Total Hip Arthroplasty: Results from a Randomized Placebo-Controlled Clinical Trial.
    J Bone Miner Res. 2019 Oct 7. doi: 10.1002/jbmr.3883.
    PubMed     Text format     Abstract available


    September 2019
  9. GREGSON CL, Bergen D, Leo P, Sessions RB, et al
    A rare mutation in SMAD9 associated with high bone mass identifies the SMAD-dependent BMP signalling pathway as a potential anabolic target for osteoporosis.
    J Bone Miner Res. 2019 Sep 16. doi: 10.1002/jbmr.3875.
    PubMed     Text format     Abstract available


  10. DALY RM, Gianoudis J, Kersh ME, Bailey CA, et al
    Effects of a 12-month supervised, community-based, multi-modal exercise program followed by a 6-month research-to-practice transition on bone mineral density, trabecular micro-architecture and physical function in older adults: A randomised controlled
    J Bone Miner Res. 2019 Sep 9. doi: 10.1002/jbmr.3865.
    PubMed     Text format     Abstract available


  11. WIEPJES CM, de Blok CJM, Staphorsius AS, Nota NM, et al
    Fracture risk in trans women and trans men using long-term gender-affirming hormonal treatment: a nationwide cohort study.
    J Bone Miner Res. 2019 Sep 5. doi: 10.1002/jbmr.3862.
    PubMed     Text format     Abstract available


    August 2019
  12. SHIEH A, Greendale GA, Cauley JA, Karvonen-Gutierrez C, et al
    Estradiol and follicle stimulating hormone as predictors of onset of menopause transition-related bone loss in pre- and perimenopausal women.
    J Bone Miner Res. 2019 Aug 23. doi: 10.1002/jbmr.3856.
    PubMed     Text format     Abstract available


  13. BOUXSEIN ML, Eastell R, Liu LY, Wu LA, et al
    Reply to: Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials.
    J Bone Miner Res. 2019 Aug 21. doi: 10.1002/jbmr.3837.
    PubMed     Text format    


  14. ANASTASILAKIS AD, Papapoulos SE, Polyzos SA, Appelman-Dijkstra NM, et al
    Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-year Clinical Trial.
    J Bone Miner Res. 2019 Aug 21. doi: 10.1002/jbmr.3853.
    PubMed     Text format     Abstract available


  15. BERGMANN PJ
    Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials.
    J Bone Miner Res. 2019 Aug 21. doi: 10.1002/jbmr.3835.
    PubMed     Text format    


  16. COSMAN F, McMahon D, Dempster D, Nieves JW, et al
    Standard vs Cyclic Teriparatide and Denosumab Treatment for Osteoporosis: A Randomized Trial.
    J Bone Miner Res. 2019 Aug 16. doi: 10.1002/jbmr.3850.
    PubMed     Text format     Abstract available


  17. LEDER B, Zapalowski C, Hu MY, Hattersley G, et al
    Fracture and Bone Mineral Density Response by Baseline Risk in Patients Treated With Abaloparatide Followed by Alendronate: Results From the Phase 3 ACTIVExtend Trial.
    J Bone Miner Res. 2019 Aug 14. doi: 10.1002/jbmr.3848.
    PubMed     Text format     Abstract available


  18. BLIUC D, Tran T, van Geel T, Adachi JD, et al
    Reduced Bone Loss Is Associated With Reduced Mortality Risk in Subjects Exposed to Nitrogen Bisphosphonates: A Mediation Analysis.
    J Bone Miner Res. 2019 Aug 12. doi: 10.1002/jbmr.3816.
    PubMed     Text format     Abstract available


  19. SCHOUSBOE JT, Lix LM, Morin SN, Derkatch S, et al
    Vertebral Fracture Assessment Increases Use of Pharmacologic Therapy for Fracture Prevention in Clinical Practice.
    J Bone Miner Res. 2019 Aug 1. doi: 10.1002/jbmr.3836.
    PubMed     Text format     Abstract available


    July 2019
  20. CARR A, Kerr SJ, Richardson R, Ebeling P, et al
    Prolonged effect of zoledronic acid on bone mineral density and turnover in HIV-infected adults on tenofovir: a randomized, open-label study.
    J Bone Miner Res. 2019 Jul 30. doi: 10.1002/jbmr.3834.
    PubMed     Text format     Abstract available


  21. ROBINSON ME, Trejo P, Palomo T, Glorieux FH, et al
    Osteogenesis Imperfecta: Skeletal Outcomes After Bisphosphonate Discontinuation at Final Height.
    J Bone Miner Res. 2019 Jul 29. doi: 10.1002/jbmr.3833.
    PubMed     Text format     Abstract available


  22. ZHAO J, Huang M, Zhang X, Xu J, et al
    MiR-146a deletion protects from bone loss in OVX mice by suppressing RANKL/OPG and M-CSF in bone microenvironment.
    J Bone Miner Res. 2019 Jul 29. doi: 10.1002/jbmr.3832.
    PubMed     Text format     Abstract available


  23. COHEN A, Kamanda-Kosseh M, Dempster DW, Zhou H, et al
    Women With Pregnancy and Lactation-Associated Osteoporosis (PLO) Have Low Bone Remodeling Rates at the Tissue Level.
    J Bone Miner Res. 2019 Jul 26. doi: 10.1002/jbmr.3750.
    PubMed     Text format     Abstract available


  24. LEWIS JR, Eggermont CJ, Schousboe JT, Lim WH, et al
    Association between abdominal aortic calcification, bone mineral density and fracture in older women.
    J Bone Miner Res. 2019 Jul 16. doi: 10.1002/jbmr.3830.
    PubMed     Text format     Abstract available


  25. BORGEN TT, Bjornerem A, Solberg LB, Andreasen C, et al
    Post-Fracture Risk Assessment: Target Central Sited Fractures First! A Sub-Study of NoFRACT.
    J Bone Miner Res. 2019 Jul 16. doi: 10.1002/jbmr.3827.
    PubMed     Text format     Abstract available


  26. MENALE C, Robinson LJ, Palagano E, Rigoni R, et al
    Absence of Dipeptidyl Peptidase 3 increases oxidative stress and causes bone loss.
    J Bone Miner Res. 2019 Jul 11. doi: 10.1002/jbmr.3829.
    PubMed     Text format     Abstract available


  27. MIYAOKA D, Inaba M, Imanishi Y, Hayashi N, et al
    Denosumab improves glomerular filtration rate in osteoporotic patients with normal kidney function by lowering serum phosphorus.
    J Bone Miner Res. 2019 Jul 5. doi: 10.1002/jbmr.3821.
    PubMed     Text format     Abstract available


  28. LEE RH, Sloane R, Pieper C, Lyles KW, et al
    Glycemic control and insulin treatment alter fracture risk in older men with type 2 diabetes mellitus.
    J Bone Miner Res. 2019 Jul 3. doi: 10.1002/jbmr.3826.
    PubMed     Text format     Abstract available


    June 2019
  29. LEDER BZ, Clarke BL, Shane E, Khosla S, et al
    A Lot of Progress, with More to Be Done: A Response to NIH Pathways to Prevention Report "Research Gaps for Long-Term Drug Therapies for Osteoporotic Fracture Prevention".
    J Bone Miner Res. 2019 Jun 25. doi: 10.1002/jbmr.3823.
    PubMed     Text format     Abstract available


  30. CHAVASSIEUX P, Chapurlat R, Portero-Muzy N, Roux JP, et al
    Bone-Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment.
    J Bone Miner Res. 2019 Jun 24. doi: 10.1002/jbmr.3735.
    PubMed     Text format     Abstract available


  31. ZHU K, Lewis JR, Sim M, Prince RL, et al
    Low vitamin D status is associated with impaired bone quality and increased risk of fracture-related hospitalization in older Australian women.
    J Bone Miner Res. 2019 Jun 24. doi: 10.1002/jbmr.3818.
    PubMed     Text format     Abstract available


  32. ALLISTON T, Schafer A
    Bone Quality Sleuths: Uncovering Tissue-Level Mechanisms of Bone Fragility in Human Type 2 Diabetes.
    J Bone Miner Res. 2019 Jun 21. doi: 10.1002/jbmr.3749.
    PubMed     Text format    


  33. LESLIE WD, Morin SN, Martineau P, Bryanton M, et al
    Association of Bone Density Monitoring in Routine Clinical Practice with Anti-Osteoporosis Medication Use and Incident Fractures: A Matched Cohort Study.
    J Bone Miner Res. 2019 Jun 18. doi: 10.1002/jbmr.3813.
    PubMed     Text format     Abstract available


  34. ZHENG J, Maerz W, Gergei I, Kleber M, et al
    Mendelian Randomization analysis reveals a causal influence of circulating sclerostin levels on bone mineral density and fractures.
    J Bone Miner Res. 2019 Jun 6. doi: 10.1002/jbmr.3803.
    PubMed     Text format     Abstract available


    May 2019
  35. DIAMOND T, Clark W, Bird P, Gonski P, et al
    Percutaneous Vertebroplasty for Acute Painful Osteoporotic Vertebral Fractures-Benefits Shown in VAPOUR Trial Masked When Pooled With Other Clinical Trials.
    J Bone Miner Res. 2019 May 28. doi: 10.1002/jbmr.3725.
    PubMed     Text format    


  36. KE K, Chen TH, Arra M, Mbalaviele G, et al
    Attenuation of NF-kappaB in intestinal epithelial cells is sufficient to mitigate the bone loss co-morbidity of experimental mouse colitis.
    J Bone Miner Res. 2019 May 20. doi: 10.1002/jbmr.3759.
    PubMed     Text format     Abstract available


  37. ZENG Q, Li N, Wang Q, Feng J, et al
    The prevalence of osteoporosis in China, a nationwide, multicenter DXA survey.
    J Bone Miner Res. 2019 May 8. doi: 10.1002/jbmr.3757.
    PubMed     Text format     Abstract available


    March 2019
  38. FERRARI S, Libanati C, Cjf L, Brown JP, et al
    Relationship Between Bone Mineral Density T-score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment.
    J Bone Miner Res. 2019 Mar 28. doi: 10.1002/jbmr.3722.
    PubMed     Text format     Abstract available


  39. FARR J, Rowsey J, Eckhardt B, Thicke B, et al
    Independent Roles of Estrogen Deficiency and Cellular Senescence in the Pathogenesis of Osteoporosis: Evidence in Young Adult Mice and Older Humans.
    J Bone Miner Res. 2019 Mar 26. doi: 10.1002/jbmr.3729.
    PubMed     Text format     Abstract available


  40. ZEBAZE R, Osima M, Bui M, Lukic M, et al
    Adding Marrow Adiposity and Cortical Porosity to Femoral Neck Areal Bone Mineral Density Improves the Discrimination of Women with Nonvertebral Fractures from Controls.
    J Bone Miner Res. 2019 Mar 18. doi: 10.1002/jbmr.3721.
    PubMed     Text format     Abstract available


  41. KEMP JP, Sayers A, Fraser WD, Davey Smith G, et al
    A Metabolic Screen in Adolescents Reveals an Association Between Circulating Citrate and Cortical Bone Mineral Density.
    J Bone Miner Res. 2019 Mar 18:e3697. doi: 10.1002/jbmr.3697.
    PubMed     Text format     Abstract available


  42. WATSON S, Weeks B, Weis L, Harding A, et al
    High-Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical Function in Postmenopausal Women With Osteopenia and Osteoporosis: The LIFTMOR Randomized Controlled Trial.
    J Bone Miner Res. 2019;34:572.
    PubMed     Text format    


    February 2019
  43. QAZI SL, Sirola J, Kroger H, Honkanen R, et al
    High Postural Sway Is an Independent Risk Factor for Osteoporotic Fractures but Not for Mortality in Elderly Women.
    J Bone Miner Res. 2019 Feb 27:e3664. doi: 10.1002/jbmr.3664.
    PubMed     Text format     Abstract available


  44. MAJUMDAR SR, Lier DA, McAlister FA, Johnson JA, et al
    Cost-effectiveness of Osteoporosis Interventions to Improve Quality of Care after Upper Extremity Fracture: Results from a Randomized Trial (C-STOP Trial).
    J Bone Miner Res. 2019 Feb 19. doi: 10.1002/jbmr.3699.
    PubMed     Text format     Abstract available


  45. PISU M, Kopperdahl DL, Lewis CE, Saag KG, et al
    Cost-effectiveness of osteoporosis screening using biomechanical computed tomography for patients with a previous abdominal CT.
    J Bone Miner Res. 2019 Feb 19. doi: 10.1002/jbmr.3700.
    PubMed     Text format     Abstract available


  46. LEWIECKI EM, Binkley N, Bilezikian JP
    Treated Osteoporosis Is Still Osteoporosis.
    J Bone Miner Res. 2019 Feb 19:e3671. doi: 10.1002/jbmr.3671.
    PubMed     Text format    


  47. COLDITZ J, Thiele S, Baschant U, Garbe AI, et al
    Osteogenic Dkk1 mediates glucocorticoid-induced, but not arthritis-induced bone loss.
    J Bone Miner Res. 2019 Feb 19. doi: 10.1002/jbmr.3702.
    PubMed     Text format     Abstract available


  48. GROTSCH B, Lux A, Rombouts Y, Hoffmann AC, et al
    Fra1 controls rheumatoid factor autoantibody production by bone marrow plasma cells and the development of autoimmune bone loss.
    J Bone Miner Res. 2019 Feb 19. doi: 10.1002/jbmr.3705.
    PubMed     Text format     Abstract available


  49. WHITNEY DG, Alford AI, Devlin MJ, Caird MS, et al
    Adults with cerebral palsy have higher prevalence of fracture compared to adults without cerebral palsy independent of osteoporosis and cardiometabolic diseases.
    J Bone Miner Res. 2019 Feb 7. doi: 10.1002/jbmr.3694.
    PubMed     Text format     Abstract available


  50. BORHAN S, Papaioannou A, Gajic-Veljanoski O, Kennedy C, et al
    Incident Fragility Fractures Have a Long-Term Negative Impact on Health-Related Quality of Life of Older People: The Canadian Multicentre Osteoporosis Study.
    J Bone Miner Res. 2019 Feb 5:e3666. doi: 10.1002/jbmr.3666.
    PubMed     Text format     Abstract available


  51. GIOLLO A, Rossini M, Gatti D, Adami G, et al
    Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells.
    J Bone Miner Res. 2019 Feb 4:e3660. doi: 10.1002/jbmr.3660.
    PubMed     Text format    


    January 2019
  52. BEEK KJ, Rusman T, van der Weijden M, Lems WF, et al
    Long-term Treatment with TNF-alpha Inhibitors Improves Bone Mineral Density But Not Vertebral Fracture Progression in Ankylosing Spondylitis.
    J Bone Miner Res. 2019 Jan 28. doi: 10.1002/jbmr.3684.
    PubMed     Text format     Abstract available


  53. SCHEPPER JD, Collins FL, Rios-Arce ND, Raehtz S, et al
    Probiotic Lactobacillus reuteri Prevents Postantibiotic Bone Loss by Reducing Intestinal Dysbiosis and Preventing Barrier Disruption.
    J Bone Miner Res. 2019 Jan 28. doi: 10.1002/jbmr.3635.
    PubMed     Text format     Abstract available


  54. VAN DORT MJ, Driessen JHM, Romme E, Geusens P, et al
    Thoracic kyphosis on chest CT scans is associated with incident vertebral fractures in smokers.
    J Bone Miner Res. 2019 Jan 28. doi: 10.1002/jbmr.3672.
    PubMed     Text format     Abstract available


  55. PEI YF, Liu L, Liu TL, Yang XL, et al
    Joint association analysis identified 18 new loci for bone mineral density.
    J Bone Miner Res. 2019 Jan 28. doi: 10.1002/jbmr.3681.
    PubMed     Text format     Abstract available


  56. BOUXSEIN ML, Eastell R, Lui LY, Wu LA, et al
    Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials.
    J Bone Miner Res. 2019 Jan 23. doi: 10.1002/jbmr.3641.
    PubMed     Text format     Abstract available


  57. LENTLE B, Koromani F, Brown J, Oei L, et al
    The Radiology of Osteoporotic Vertebral Fractures Revisited.
    J Bone Miner Res. 2019 Jan 15. doi: 10.1002/jbmr.3669.
    PubMed     Text format     Abstract available


  58. CONESA FM, Llamas-Granda P, Larranaga-Vera A, Wilder T, et al
    Tenofovir causes bone loss via decreased bone formation and increased bone resorption, which can be counteracted by dipyridamole in mice.
    J Bone Miner Res. 2019 Jan 15. doi: 10.1002/jbmr.3665.
    PubMed     Text format     Abstract available


  59. FLORENZANO P, Pan KS, Brown SM, Paul SM, et al
    Age-Related Changes and Effects of Bisphosphonates on Bone Turnover and Disease Progression in Fibrous Dysplasia of Bone.
    J Bone Miner Res. 2019 Jan 15. doi: 10.1002/jbmr.3649.
    PubMed     Text format     Abstract available


  60. TATANGELO G, Watts J, Lim K, Connaughton C, et al
    The Cost of Osteoporosis, Osteopenia, and Associated Fractures in Australia in 2017.
    J Bone Miner Res. 2019 Jan 7. doi: 10.1002/jbmr.3640.
    PubMed     Text format     Abstract available


  61. ZHAO X, Ning L, Xie Z, Jie Z, et al
    The Novel p38 Inhibitor, Pamapimod, Inhibits Osteoclastogenesis and Counteracts Estrogen-Dependent Bone Loss in Mice.
    J Bone Miner Res. 2019 Jan 7. doi: 10.1002/jbmr.3655.
    PubMed     Text format     Abstract available


    December 2018
  62. CRANDALL CJ, Larson J, Manson JE, Cauley JA, et al
    A Comparison of U.S. and Canadian Osteoporosis Screening and Treatment Strategies in Postmenopausal Women.
    J Bone Miner Res. 2018 Dec 7. doi: 10.1002/jbmr.3636.
    PubMed     Text format     Abstract available


  63. KIM TY, Bauer DC, McNabb BL, Schafer AL, et al
    Comparison of BMD Changes and Bone Formation Marker Levels 3 Years After Bisphosphonate Discontinuation: FLEX and HORIZON-PFT Extension I Trials.
    J Bone Miner Res. 2018 Dec 7. doi: 10.1002/jbmr.3654.
    PubMed     Text format     Abstract available


  64. LI Z, Huang J, Wang F, Li W, et al
    Dual Targeting of Bile Acid Receptor-1 (TGR5) and Farnesoid X Receptor (FXR) Prevents Estrogen-Dependent Bone Loss in Mice.
    J Bone Miner Res. 2018 Dec 7. doi: 10.1002/jbmr.3652.
    PubMed     Text format     Abstract available


  65. LEWIECKI EM, Dinavahi RV, Lazaretti-Castro M, Ebeling PR, et al
    One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study.
    J Bone Miner Res. 2018 Dec 3. doi: 10.1002/jbmr.3622.
    PubMed     Text format     Abstract available


  66. ENGDAHL C, Bang H, Dietel K, Lang SC, et al
    Periarticular Bone Loss in Arthritis Is Induced by Autoantibodies Against Citrullinated Vimentin.
    J Bone Miner Res. 2018;33:2243.
    PubMed     Text format    


    November 2018
  67. EVENEPOEL P, Claes K, Meijers B, Laurent M, et al
    Poor Vitamin K Status Is Associated With Low Bone Mineral Density and Increased Fracture Risk in End-Stage Renal Disease.
    J Bone Miner Res. 2018 Nov 14. doi: 10.1002/jbmr.3608.
    PubMed     Text format     Abstract available


  68. LI JY, Yu M, Tyagi AM, Vaccaro C, et al
    IL-17 Receptor Signaling in Osteoblasts/Osteocytes Mediates PTH-Induced Bone Loss and Enhances Osteocytic RANKL Production.
    J Bone Miner Res. 2018 Nov 6. doi: 10.1002/jbmr.3600.
    PubMed     Text format     Abstract available


  69. AXELSSON KF, Lorentzon M
    Reply to: Bariatric Surgery, Physical Activity, and Fracture Risk.
    J Bone Miner Res. 2018 Nov 6. doi: 10.1002/jbmr.3592.
    PubMed     Text format    


  70. SUGIYAMA T
    Bariatric Surgery, Physical Activity, and Fracture Risk.
    J Bone Miner Res. 2018 Nov 5. doi: 10.1002/jbmr.3593.
    PubMed     Text format    


  71. PRINCE RL, Lewis JR, Lim WH, Wong G, et al
    Adding Lateral Spine Imaging for Vertebral Fractures to Densitometric Screening: Improving Ascertainment of Patients at High Risk of Incident Osteoporotic Fractures.
    J Bone Miner Res. 2018 Nov 5. doi: 10.1002/jbmr.3595.
    PubMed     Text format     Abstract available


    October 2018
  72. AQUINO-MARTINEZ R, Farr JN, Weivoda MM, Negley BA, et al
    miR-219a-5p Regulates Rorbeta During Osteoblast Differentiation and in Age-related Bone Loss.
    J Bone Miner Res. 2018 Oct 15. doi: 10.1002/jbmr.3586.
    PubMed     Text format     Abstract available


  73. JIANG M, Wang T, Yan X, Liu Z, et al
    A novel rhein derivative modulates bone formation and resorption and ameliorates oestrogen-dependent bone loss.
    J Bone Miner Res. 2018 Oct 15. doi: 10.1002/jbmr.3604.
    PubMed     Text format     Abstract available


  74. JAKOB F, Ebert R, Fernandez-Rebollo E, Bischof O, et al
    Response to Letter to the Editor: Epigenetic Aging in Osteoporosis.
    J Bone Miner Res. 2018;33:1904-1905.
    PubMed     Text format    


    September 2018
  75. EMAMI AJ, Toupadakis CA, Telek SM, Fyhrie DP, et al
    Age dependence of systemic bone loss and recovery following femur fracture in mice.
    J Bone Miner Res. 2018 Sep 6. doi: 10.1002/jbmr.3579.
    PubMed     Text format     Abstract available


    August 2018
  76. CHANG PY, Feldman D, Stefanick ML, McDonnell DP, et al
    27-hydroxycholesterol, an endogenous SERM, and risk of fracture in postmenopausal women: A nested case-cohort study in the Women's Health Initiative.
    J Bone Miner Res. 2018 Aug 23. doi: 10.1002/jbmr.3576.
    PubMed     Text format     Abstract available


  77. DEL REAL A, Riancho-Zarrabeitia L, Riancho JA
    EPIGENETIC AGING IN OSTEOPOROSIS.
    J Bone Miner Res. 2018 Aug 14. doi: 10.1002/jbmr.3567.
    PubMed     Text format     Abstract available


    July 2018
  78. MAJUMDAR SR, McAlister FA, Johnson JA, Rowe BH, et al
    Comparing Strategies Targeting Osteoporosis to Prevent Fractures after an Upper Extremity Fracture (C-STOP Trial): A Randomized Controlled Trial.
    J Bone Miner Res. 2018 Jul 24. doi: 10.1002/jbmr.3557.
    PubMed     Text format     Abstract available


  79. CIPRIANI C, Pepe J, Silva BC, Rubin MR, et al
    Comparative Effect of rhPTH(1-84) on Bone Mineral Density and Trabecular Bone Score in Hypoparathyroidism and Postmenopausal Osteoporosis.
    J Bone Miner Res. 2018 Jul 24. doi: 10.1002/jbmr.3554.
    PubMed     Text format     Abstract available


  80. OEI E, Rivadeneira F, Koromani F, Oei L, et al
    Letter to the Editor: Osteoporotic vertebral fracture prevalence varies widely (response to M18050319).
    J Bone Miner Res. 2018 Jul 16. doi: 10.1002/jbmr.3547.
    PubMed     Text format     Abstract available


  81. HARVEY NC, Oden A, Orwoll E, Lapidus J, et al
    Measures of physical performance and muscle strength as predictors of fracture risk independent of FRAX, falls and BMD: A meta-analysis of the Osteoporotic Fractures in Men (MrOS) Study.
    J Bone Miner Res. 2018 Jul 16. doi: 10.1002/jbmr.3556.
    PubMed     Text format     Abstract available


  82. AXELSSON KF, Werling M, Eliasson B, Szabo E, et al
    Fracture risk after gastric bypass surgery-a retrospective cohort study.
    J Bone Miner Res. 2018 Jul 16. doi: 10.1002/jbmr.3553.
    PubMed     Text format     Abstract available


  83. SROGA GE, Vashishth D
    Phosphorylation of extracellular bone matrix proteins and its contribution to bone fragility.
    J Bone Miner Res. 2018 Jul 12. doi: 10.1002/jbmr.3552.
    PubMed     Text format     Abstract available


    June 2018
  84. GILCHRIST DN, Quayle J, Hamilton G, Te Momo L, et al
    Osteoporotic vertebral fracture prevalence varies widely.
    J Bone Miner Res. 2018 Jun 29. doi: 10.1002/jbmr.3541.
    PubMed     Text format     Abstract available


  85. SZULC P
    Osteoporotic vertebral fracture prevalence varies widely - answer.
    J Bone Miner Res. 2018 Jun 29. doi: 10.1002/jbmr.3542.
    PubMed     Text format     Abstract available


  86. GOLTZMAN D, Lentle BC
    Osteoporotic vertebral fractures (response to M18050319).
    J Bone Miner Res. 2018 Jun 29. doi: 10.1002/jbmr.3540.
    PubMed     Text format     Abstract available


  87. LESLIE WD, Johansson H, McCloskey EV, Harvey NC, et al
    Comparison of Methods for Improving Fracture Risk Assessment in Diabetes: The Manitoba BMD Registry.
    J Bone Miner Res. 2018 Jun 28. doi: 10.1002/jbmr.3538.
    PubMed     Text format     Abstract available


  88. LANGDAHL BL
    Is There a Place for Bone Turnover Markers in the Management of Osteoporosis?
    J Bone Miner Res. 2018 Jun 21. doi: 10.1002/jbmr.3478.
    PubMed     Text format    


  89. CHEISHVILI D, Parashar S, Mahmood N, Arakelian A, et al
    Identification of an Epigenetic Signature of Osteoporosis in Blood DNA of Post-menopausal Women.
    J Bone Miner Res. 2018 Jun 20. doi: 10.1002/jbmr.3527.
    PubMed     Text format     Abstract available


  90. RUBIN KH, Moller S, Holmberg T, Bliddal M, et al
    A New Fracture Risk Assessment Tool (FREM) Based on Public Health Registries.
    J Bone Miner Res. 2018 Jun 20. doi: 10.1002/jbmr.3528.
    PubMed     Text format     Abstract available


  91. BALASUBRAMANIAN A, Wade SW, Adler RA, Saag K, et al
    Glucocorticoid exposure and fracture risk in a cohort of US patients with selected conditions.
    J Bone Miner Res. 2018 Jun 20. doi: 10.1002/jbmr.3523.
    PubMed     Text format     Abstract available


  92. CRANDALL CJ, Vasan S, LaCroix A, LeBoff MS, et al
    Bone Turnover Markers Are Not Associated With Hip Fracture Risk: A Case-Control Study in the Women's Health Initiative.
    J Bone Miner Res. 2018 Jun 19. doi: 10.1002/jbmr.3471.
    PubMed     Text format     Abstract available


  93. EDWARDS WB, Simonian N, Haider IT, Anschel AS, et al
    Effects of Teriparatide and Vibration on Bone Mass and Bone Strength in People with Bone Loss and Spinal Cord Injury: A Randomized, Controlled Trial.
    J Bone Miner Res. 2018 Jun 15. doi: 10.1002/jbmr.3525.
    PubMed     Text format     Abstract available


  94. ALOIA JF, Fazzari M, Islam S, Mikhail M, et al
    Vitamin D Supplementation in Elderly Black Women Does Not Prevent Bone Loss, a Randomized Controlled Trial.
    J Bone Miner Res. 2018 Jun 15. doi: 10.1002/jbmr.3521.
    PubMed     Text format     Abstract available


    May 2018
  95. LIU CT, Sahni S, Xu H, McLean RR, et al
    Long-Term and Recent Weight Change are Associated with Reduced Peripheral Bone Density, Deficits in Bone Microarchitecture, and Decreased Bone Strength: The Framingham Osteoporosis Study.
    J Bone Miner Res. 2018 May 29. doi: 10.1002/jbmr.3472.
    PubMed     Text format     Abstract available


  96. KRISTJANSDOTTIR HL, Lewerin C, Lerner UH, Waern E, et al
    High Serum Serotonin Predicts Increased Risk for Hip Fracture and Nonvertebral Osteoporotic Fractures: The MrOS Sweden Study.
    J Bone Miner Res. 2018 May 11. doi: 10.1002/jbmr.3443.
    PubMed     Text format     Abstract available


  97. CAULEY JA, Burghardt AJ, Harrison SL, Cawthon PM, et al
    Accelerated bone loss in older men: Effects on bone microarchitecture and strength.
    J Bone Miner Res. 2018 May 11. doi: 10.1002/jbmr.3468.
    PubMed     Text format     Abstract available


  98. LENTLE BC, Oei E, Goltzman D, Rivadeneira F, et al
    Vertebral fractures and morphometric deformities.
    J Bone Miner Res. 2018 May 11. doi: 10.1002/jbmr.3470.
    PubMed     Text format     Abstract available


  99. COSMAN F, Crittenden DB, Ferrari S, Lewiecki EM, et al
    Romosozumab FRAME Study: A Post Hoc Analysis of the Role of Regional Background Fracture Risk on Nonvertebral Fracture Outcome.
    J Bone Miner Res. 2018 May 11. doi: 10.1002/jbmr.3439.
    PubMed     Text format     Abstract available


  100. EJLSMARK-SVENSSON H, Bislev LS, Lajlev S, Harslof T, et al
    Prevalence and risk of Vertebral Fractures in Primary Hyperparathyroidism: A nested case-control study.
    J Bone Miner Res. 2018 May 7. doi: 10.1002/jbmr.3461.
    PubMed     Text format     Abstract available


  101. SALIMI S, Shardell M, Miller R, Gruber-Baldini AL, et al
    Soluble tumor necrosis factor alpha receptor1, bone resorption and bone mineral density in the year following hip fractures: The Baltimore Hip Studies.
    J Bone Miner Res. 2018 May 7. doi: 10.1002/jbmr.3457.
    PubMed     Text format     Abstract available


    April 2018
  102. BUEHRING B, Hansen KE, Lewis BL, Cummings SR, et al
    Dysmobility Syndrome Independently Increases Fracture Risk in the Osteoporotic Fractures in Men (MrOS) Prospective Cohort Study.
    J Bone Miner Res. 2018 Apr 27. doi: 10.1002/jbmr.3455.
    PubMed     Text format     Abstract available


  103. MCCLUNG MR, Brown JP, Diez-Perez A, Resch H, et al
    Effects of 24 months of treatment with romosozumab followed by 12 months of denosumab or placebo in postmenopausal women with low bone mineral density: A randomized, double-blind, phase 2, parallel group study.
    J Bone Miner Res. 2018 Apr 25. doi: 10.1002/jbmr.3452.
    PubMed     Text format     Abstract available


  104. BERGLUND JA, Tella SH, Tuthill KF, Kim L, et al
    Scoliosis in Fibrous Dysplasia/McCune-Albright Syndrome: Factors Associated with Curve Progression and Effects of Bisphosphonates.
    J Bone Miner Res. 2018 Apr 18. doi: 10.1002/jbmr.3446.
    PubMed     Text format     Abstract available


  105. ADAMS AL, Fischer H, Kopperdahl DL, Lee DC, et al
    Osteoporosis and Hip Fracture Risk From Routine Computed Tomography Scans: The Fracture, Osteoporosis, and CT Utilization Study (FOCUS).
    J Bone Miner Res. 2018 Apr 17. doi: 10.1002/jbmr.3423.
    PubMed     Text format     Abstract available


  106. NAYAK S, Greenspan SL
    How Can We Improve Osteoporosis Care: A Systematic Review and Meta-Analysis of the Efficacy of Quality Improvement Strategies for Osteoporosis.
    J Bone Miner Res. 2018 Apr 10. doi: 10.1002/jbmr.3437.
    PubMed     Text format     Abstract available


  107. BEGIN MJ, Ste-Marie LG, Coupal L, Ethier J, et al
    Hypomagnesemia During Teriparatide Treatment in Osteoporosis: Incidence and Determinants.
    J Bone Miner Res. 2018 Apr 10. doi: 10.1002/jbmr.3438.
    PubMed     Text format     Abstract available


  108. LANGSETMO L, Peters KW, Burghardt AJ, Ensrud KE, et al
    Volumetric Bone Mineral Density and Failure Load of Distal Limbs Predict Incident Clinical Fracture Independent of FRAX and Clinical Risk Factors Among Older Men.
    J Bone Miner Res. 2018 Apr 6. doi: 10.1002/jbmr.3433.
    PubMed     Text format     Abstract available


    March 2018
  109. YU EW
    Bariatric Surgery: Weighing In on Bone Loss.
    J Bone Miner Res. 2018 Mar 30. doi: 10.1002/jbmr.3432.
    PubMed     Text format     Abstract available


  110. COSMAN F, Crittenden DB, Ferrari S, Khan A, et al
    FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab.
    J Bone Miner Res. 2018 Mar 24. doi: 10.1002/jbmr.3427.
    PubMed     Text format     Abstract available


  111. VAN DORT MJ, Geusens PPPM, Driessen JHM, Romme EAPM, et al
    High imminent vertebral fracture risk in subjects with COPD with a prevalent or incident vertebral fracture.
    J Bone Miner Res. 2018 Mar 23. doi: 10.1002/jbmr.3429.
    PubMed     Text format     Abstract available


  112. VAN VLIET NA, Noordam R, Van Klinken JB, Westendorp RGJ, et al
    Thyroid stimulating hormone and bone mineral density: Evidence from a two-sample Mendelian randomization study and a candidate gene association study.
    J Bone Miner Res. 2018 Mar 15. doi: 10.1002/jbmr.3426.
    PubMed     Text format     Abstract available


  113. OLVERA D, Stolzenfeld R, Marini JC, Caird MS, et al
    Low dose of bisphosphonate enhances sclerostin antibody-induced trabecular bone mass gains in Brtl/+ osteogenesis imperfecta mouse model.
    J Bone Miner Res. 2018 Mar 15. doi: 10.1002/jbmr.3421.
    PubMed     Text format     Abstract available


  114. ABRAHAMSEN B
    The changing role of patient education in osteoporosis.
    J Bone Miner Res. 2018 Mar 12. doi: 10.1002/jbmr.3425.
    PubMed     Text format     Abstract available


  115. ZHU DL, Chen XF, Hu WX, Dong SS, et al
    Multiple functional variants at 13q14 risk locus for osteoporosis regulate RANKL expression through long-range super-enhancer.
    J Bone Miner Res. 2018 Mar 12. doi: 10.1002/jbmr.3419.
    PubMed     Text format     Abstract available


  116. ADAMS AL, Adams JL, Raebel MA, Tang BT, et al
    Bisphosphonate Drug Holiday and Fracture Risk: A Population-Based Cohort Study.
    J Bone Miner Res. 2018 Mar 12. doi: 10.1002/jbmr.3420.
    PubMed     Text format     Abstract available


  117. GILLESPIE CW, Morin PE
    Osteoporosis-Related Health Services Utilization Following First Hip Fracture Among a Cohort of Privately-Insured Women in the United States, 2008-2014: An Observational Study.
    J Bone Miner Res. 2018;33:549.
    PubMed     Text format    


    February 2018
  118. MCCLOSKEY E, Johansson H, Harvey NC, Shepstone L, et al
    Management of patients with high baseline hip fracture risk by FRAX reduces hip fractures - a post hoc analysis of the SCOOP Study.
    J Bone Miner Res. 2018 Feb 26. doi: 10.1002/jbmr.3411.
    PubMed     Text format     Abstract available


  119. MULLIN BH, Zhu K, Xu J, Brown SJ, et al
    Expression quantitative trait locus study of bone mineral density GWAS variants in human osteoclasts.
    J Bone Miner Res. 2018 Feb 23. doi: 10.1002/jbmr.3412.
    PubMed     Text format     Abstract available


  120. TURNER DA, Khioe RFS, Shepstone L, Lenaghan E, et al
    The Cost-Effectiveness of Screening in the Community to Reduce Osteoporotic Fractures in Older Women in the UK: Economic Evaluation of the SCOOP Study.
    J Bone Miner Res. 2018 Feb 22. doi: 10.1002/jbmr.3381.
    PubMed     Text format     Abstract available


  121. SHIN DW, Suh B, Lim H, Yun JM, et al
    J-shaped Association between Post-operative Levothyroxine Dosage and Fracture Risk in Thyroid Cancer Patients: a Retrospective Cohort Study.
    J Bone Miner Res. 2018 Feb 15. doi: 10.1002/jbmr.3407.
    PubMed     Text format     Abstract available


  122. SZULC P
    Vertebral fracture - diagnostic difficulties of a major medical problem.
    J Bone Miner Res. 2018 Feb 8. doi: 10.1002/jbmr.3404.
    PubMed     Text format     Abstract available


  123. MANOLAGAS SC
    The quest for osteoporosis mechanisms and rational therapies: How far we've come, how much further we need to go.
    J Bone Miner Res. 2018 Feb 5. doi: 10.1002/jbmr.3400.
    PubMed     Text format     Abstract available


  124. LAMY O, Gonzalez-Rodriguez E
    Underestimation of vertebral fractures after Denosumab discontinuation.
    J Bone Miner Res. 2018 Feb 2. doi: 10.1002/jbmr.3370.
    PubMed     Text format     Abstract available


    January 2018
  125. DANILA MI, Outman RC, Rahn EJ, Mudano AS, et al
    Evaluation of a Multi-modal, Direct-to-Patient Educational Intervention Targeting Barriers to Osteoporosis: A Randomized Clinical Trial.
    J Bone Miner Res. 2018 Jan 26. doi: 10.1002/jbmr.3395.
    PubMed     Text format     Abstract available


  126. XIAO L, Zhou Y, Zhu L, Yang S, et al
    SPHK1-S1PR1-RANKL axis regulates the interactions between macrophages and BMSCs in inflammatory bone loss.
    J Bone Miner Res. 2018 Jan 26. doi: 10.1002/jbmr.3396.
    PubMed     Text format     Abstract available


  127. ACEVEDO C, Sylvia M, Schaible E, Graham JL, et al
    Contributions of material properties and structure to increased bone fragility for a given bone mass in the UCD-T2DM rat model of type 2 diabetes.
    J Bone Miner Res. 2018 Jan 17. doi: 10.1002/jbmr.3393.
    PubMed     Text format     Abstract available


  128. LARSSON SC, Melhus H, Michaelsson K
    Circulating Serum 25-Hydroxyvitamin D Levels and Bone Mineral Density: Mendelian Randomization Study.
    J Bone Miner Res. 2018 Jan 16. doi: 10.1002/jbmr.3389.
    PubMed     Text format     Abstract available


  129. GEUSENS P, Marin F, Kendler DL, Russo LA, et al
    Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial.
    J Bone Miner Res. 2018 Jan 12. doi: 10.1002/jbmr.3384.
    PubMed     Text format     Abstract available


  130. BAUER DC, Black DM, Bouxsein ML, Lui LY, et al
    Treatment-Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Anti-Resorptive Drugs: A Meta-Regression.
    J Bone Miner Res. 2018 Jan 10. doi: 10.1002/jbmr.3355.
    PubMed     Text format     Abstract available


  131. LEE SJ, Graffy PM, Zea RD, Ziemlewicz TJ, et al
    Future Osteoporotic Fracture Risk related to Lumbar Vertebral Trabecular Attenuation Measured at Routine Body CT.
    J Bone Miner Res. 2018 Jan 3. doi: 10.1002/jbmr.3383.
    PubMed     Text format     Abstract available


    December 2017
  132. DOU C, Ding N, Zhao C, Hou T, et al
    Estrogen Deficiency-Mediated M2 Macrophage Osteoclastogenesis Contributes to M1/M2 Ratio Alteration in Ovariectomized Osteoporotic Mice.
    J Bone Miner Res. 2017 Dec 27. doi: 10.1002/jbmr.3364.
    PubMed     Text format     Abstract available


  133. NGUYEN TV, Eisman JA
    Assessment of fracture risk: Population association vs individual prediction.
    J Bone Miner Res. 2017 Dec 27. doi: 10.1002/jbmr.3367.
    PubMed     Text format     Abstract available


  134. CHU X, Zhu Y, Wang O, Nie M, et al
    Bone mineral density and its serial changes are associated with PTH levels in pseudohypoparathyroidism type 1B patients.
    J Bone Miner Res. 2017 Dec 14. doi: 10.1002/jbmr.3360.
    PubMed     Text format     Abstract available


  135. MOAYYERI A, Cheung CL, Tan KC, Morris JA, et al
    Metabolomic pathways to osteoporosis in middle-aged women: A genome-metabolome-wide Mendelian randomization study.
    J Bone Miner Res. 2017 Dec 12. doi: 10.1002/jbmr.3358.
    PubMed     Text format     Abstract available


  136. LEDER B
    An Essential Warning: Editorial on Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial, Its Extension.
    J Bone Miner Res. 2017 Dec 12. doi: 10.1002/jbmr.3359.
    PubMed     Text format     Abstract available


  137. YANG Y, Wu F, Winzenberg T, Jones G, et al
    Tracking of areal bone mineral density from age eight to young adulthood and factors associated with deviation from tracking: a 17-yr prospective cohort study.
    J Bone Miner Res. 2017 Dec 12. doi: 10.1002/jbmr.3361.
    PubMed     Text format     Abstract available


  138. HARVEY NC, Oden A, Orwoll E, Lapidus J, et al
    Falls Predict Fractures Independently of FRAX Probability: A Meta-Analysis of the Osteoporotic Fractures in Men (MrOS) Study.
    J Bone Miner Res. 2017 Dec 8. doi: 10.1002/jbmr.3331.
    PubMed     Text format     Abstract available


  139. BJORNEREM A, Wang X, Bui M, Ghasem-Zadeh A, et al
    Menopause-Related Appendicular Bone Loss is Mainly Cortical and Results in Increased Cortical Porosity.
    J Bone Miner Res. 2017 Dec 8. doi: 10.1002/jbmr.3333.
    PubMed     Text format     Abstract available


  140. STONE KL, Lui LY, Christen WG, Troen AM, et al
    Effect of Combination Folic Acid, Vitamin B6 , and Vitamin B12 Supplementation on Fracture Risk in Women: A Randomized, Controlled Trial.
    J Bone Miner Res. 2017;32:2331-2338.
    PubMed     Text format     Abstract available


    November 2017
  141. CHEN W, Zhu G, Jules J, Nguyen D, et al
    Monocyte-specific knockout of C/ebpalpha results in osteopetrosis phenotype, blocks bone loss in ovariectomized mice and reveals an important function of C/ebpalpha in osteoclast differentiation and function.
    J Bone Miner Res. 2017 Nov 17. doi: 10.1002/jbmr.3342.
    PubMed     Text format     Abstract available


  142. CUMMINGS SR, Ferrari S, Eastell R, Gilchrist N, et al
    Vertebral Fractures Following Discontinuation of Denosumab: a Post-hoc Analysis of the Randomized Placebo-controlled FREEDOM Trial and its Extension.
    J Bone Miner Res. 2017 Nov 4. doi: 10.1002/jbmr.3337.
    PubMed     Text format     Abstract available


    October 2017
  143. NAPOLI N, Schwartz AV, Black DM
    Vertebral Fracture Risk in Diabetic Elderly Men: The MrOS Study.
    J Bone Miner Res. 2017 Oct 27. doi: 10.1002/jbmr.3322.
    PubMed     Text format     Abstract available


  144. STARUP-LINDE J, Hygum K, Harslof T, Langdahl BL, et al
    Indications of increased vertebral fracture risk in patients with type 2 diabetes.
    J Bone Miner Res. 2017 Oct 27. doi: 10.1002/jbmr.3323.
    PubMed     Text format     Abstract available


  145. AMICHE MA, Levesque LE, Gomes T, Adachi JD, et al
    Effectiveness of oral bisphosphonates in reducing fracture risk among oral glucocorticoid users: three matched cohort analyses.
    J Bone Miner Res. 2017 Oct 25. doi: 10.1002/jbmr.3318.
    PubMed     Text format     Abstract available


  146. COUSMINER DL, Mitchell JA, Chesi A, Roy SM, et al
    Genetically determined later puberty impacts lowered bone mineral density in childhood and adulthood.
    J Bone Miner Res. 2017 Oct 25. doi: 10.1002/jbmr.3320.
    PubMed     Text format     Abstract available


  147. CAMPBELL GM, Tower RJ, Damm T, Kneissl P, et al
    Tracking the progression of osteolytic and osteosclerotic lesions in mice using serial in vivo micro-CT: Applications to the assessment of bisphosphonate treatment efficacy.
    J Bone Miner Res. 2017 Oct 18. doi: 10.1002/jbmr.3317.
    PubMed     Text format     Abstract available


  148. NOEL SE, Mangano KM, Griffith JL, Wright NC, et al
    Prevalence of osteoporosis and low bone mass among Puerto Rican older adults.
    J Bone Miner Res. 2017 Oct 17. doi: 10.1002/jbmr.3315.
    PubMed     Text format     Abstract available


  149. DAI Z, Zhang Y, Lu N, Felson DT, et al
    Association between dietary fiber intake and bone loss in the Framingham Offspring Study.
    J Bone Miner Res. 2017 Oct 12. doi: 10.1002/jbmr.3308.
    PubMed     Text format     Abstract available


  150. VERROKEN C, Zmierczak HG, Goemaere S, Kaufman JM, et al
    Bone turnover in young adult men: cross-sectional determinants and associations with prospectively assessed bone loss.
    J Bone Miner Res. 2017 Oct 7. doi: 10.1002/jbmr.3303.
    PubMed     Text format     Abstract available


  151. WATSON SL, Weeks BK, Weis LJ, Harding AT, et al
    High-Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical Function in Postmenopausal Women With Osteopenia and Osteoporosis: The LIFTMOR Randomized Controlled Trial.
    J Bone Miner Res. 2017 Oct 4. doi: 10.1002/jbmr.3284.
    PubMed     Text format     Abstract available


    September 2017
  152. BIVER E, Durosier-Izart C, Chevalley T, van Rietbergen B, et al
    Evaluation of radius microstructure and areal bone mineral density improves fracture prediction in postmenopausal women.
    J Bone Miner Res. 2017 Sep 28. doi: 10.1002/jbmr.3299.
    PubMed     Text format     Abstract available


  153. FERNANDEZ-REBOLLO E, Eipel M, Seefried L, Hoffmann P, et al
    Primary osteoporosis is not reflected by disease-specific DNA methylation or accelerated epigenetic age in blood.
    J Bone Miner Res. 2017 Sep 19. doi: 10.1002/jbmr.3298.
    PubMed     Text format     Abstract available


  154. JOHANSSON L, Sundh D, Zoulakis M, Rudang R, et al
    The prevalence of vertebral fractures is associated with reduced hip bone density and inferior peripheral appendicular volumetric bone density and structure in older women.
    J Bone Miner Res. 2017 Sep 19. doi: 10.1002/jbmr.3297.
    PubMed     Text format     Abstract available


  155. FINK HA, Litwack-Harrison S, Ensrud KE, Shen J, et al
    Association of Incident, Clinically Undiagnosed Radiographic Vertebral Fractures With Follow-Up Back Pain Symptoms in Older Men: the Osteoporotic Fractures in Men (MrOS) Study.
    J Bone Miner Res. 2017 Sep 7. doi: 10.1002/jbmr.3215.
    PubMed     Text format     Abstract available


  156. NAPOLI N, Schwartz AV, Schafer AL, Vittinghoff E, et al
    Vertebral Fracture Risk in Diabetic Elderly Men: The MrOS Study.
    J Bone Miner Res. 2017 Sep 1. doi: 10.1002/jbmr.3287.
    PubMed     Text format     Abstract available


    August 2017
  157. YANG G, Hamadeh I, Katz J, Riva A, et al
    SIRT1/HERC4 Locus Associated with Bisphosphonate-Induced Osteonecrosis of the Jaw: An Exome-Wide Association Analysis.
    J Bone Miner Res. 2017 Aug 30. doi: 10.1002/jbmr.3285.
    PubMed     Text format     Abstract available


  158. FINSTERER J, Zarrouk-Mahjoub S
    Reduced bone mineral density in m.3243A > G carriers may be multifactorial.
    J Bone Miner Res. 2017 Aug 25. doi: 10.1002/jbmr.3281.
    PubMed     Text format     Abstract available


  159. AJ K, A C, Y LS, L Z, et al
    PLS3 deletions lead to severe spinal osteoporosis and disturbed bone matrix mineralization.
    J Bone Miner Res. 2017 Aug 4. doi: 10.1002/jbmr.3233.
    PubMed     Text format     Abstract available


    July 2017
  160. EL REFAEY M, McGee-Lawrence ME, Fulzele S, Kennedy EJ, et al
    Kynurenine, a Tryptophan Metabolite that Accumulates with Age, Induces Bone Loss.
    J Bone Miner Res. 2017 Jul 20. doi: 10.1002/jbmr.3224.
    PubMed     Text format     Abstract available


  161. LENTLE BC, Berger C, Probyn L, Brown JP, et al
    Comparative Analysis of the Radiology of Osteoporotic Vertebral Fractures in Women and Men: Cross-Sectional and Longitudinal Observations from the Canadian Multicentre Osteoporosis Study (CaMos).
    J Bone Miner Res. 2017 Jul 19. doi: 10.1002/jbmr.3222.
    PubMed     Text format     Abstract available


  162. BLACK DM, Cauley JA, Wagman R, Ensrud K, et al
    The Ability of a Single BMD and Fracture History Assessment to Predict Fracture Over 25 Years in Postmenopausal Women: The Study of Osteoporotic Fractures.
    J Bone Miner Res. 2017 Jul 18. doi: 10.1002/jbmr.3194.
    PubMed     Text format     Abstract available


  163. OEI L, Koromani F, Breda SJ, Schousboe JT, et al
    Osteoporotic Vertebral Fracture Prevalence Varies Widely Between Radiological Assessment Methods: The Rotterdam Study.
    J Bone Miner Res. 2017 Jul 18. doi: 10.1002/jbmr.3220.
    PubMed     Text format     Abstract available


  164. SCHOUSBOE JT
    Mortality after Osteoporotic Fractures; What Proportion is Caused by Fracture and is Preventable? A Commentary.
    J Bone Miner Res. 2017 Jul 10. doi: 10.1002/jbmr.3216.
    PubMed     Text format    


  165. R GILLIES B, A Ryan B, A Tonkin B, J Poulton I, et al
    Absence of calcitriol causes increased lactational bone loss and lower milk calcium, but does not impair post-lactation bone recovery in Cyp27b1 null mice.
    J Bone Miner Res. 2017 Jul 7. doi: 10.1002/jbmr.3217.
    PubMed     Text format     Abstract available


  166. JOHNSON KC, Bray GA, Cheskin LJ, Clark JM, et al
    The effect of intentional weight loss on fracture risk in persons with diabetes: results from the Look AHEAD Randomized Clinical Trial.
    J Bone Miner Res. 2017 Jul 5. doi: 10.1002/jbmr.3214.
    PubMed     Text format     Abstract available


    June 2017
  167. HOY JF, Grund B, Roediger M, Schwartz AV, et al
    Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial.
    J Bone Miner Res. 2017 Jun 26. doi: 10.1002/jbmr.3183.
    PubMed     Text format     Abstract available


  168. LANGDAHL JH, Frederiksen AL, Hansen SJ, Andersen PH, et al
    Mitochondrial point mutation m.3243A > G associates with lower bone mineral density, thinner cortices and reduced bone strength. A case-control study.
    J Bone Miner Res. 2017 Jun 11. doi: 10.1002/jbmr.3193.
    PubMed     Text format     Abstract available


    May 2017
  169. BINKLEY N, Blank RD, Leslie WD, Lewiecki EM, et al
    Osteoporosis in Crisis: It's Time to Focus on Fracture.
    J Bone Miner Res. 2017 May 29. doi: 10.1002/jbmr.3182.
    PubMed     Text format     Abstract available


  170. EV M, H J, A O, Nc H, et al
    The effect of abaloparatide-SC on fracture risk is independent of baseline FRAX fracture probability: A post hoc analysis of the ACTIVE study.
    J Bone Miner Res. 2017 May 5. doi: 10.1002/jbmr.3163.
    PubMed     Text format     Abstract available


    April 2017
  171. STATTIN K, Michaelsson K, Larsson SC, Wolk A, et al
    Leisure-time physical activity and risk of fracture: a cohort study of 66,940 men and women.
    J Bone Miner Res. 2017 Apr 29. doi: 10.1002/jbmr.3161.
    PubMed     Text format     Abstract available


  172. GREENBAUM J, Deng HW
    A Statistical Approach to Fine Mapping for the Identification of Potential Causal Variants Related to Bone Mineral Density.
    J Bone Miner Res. 2017 Apr 20. doi: 10.1002/jbmr.3154.
    PubMed     Text format     Abstract available


  173. ENGDAHL C, Bang H, Dietel K, Lang SC, et al
    Periarticular bone loss in arthritis is induced by autoantibodies against citrullinated vimentin.
    J Bone Miner Res. 2017 Apr 20. doi: 10.1002/jbmr.3158.
    PubMed     Text format     Abstract available


  174. YINGJIAN L, Ping W, Rui H, Xuxia L, et al
    Cadmium exposure and osteoporosis: a population-based study and benchmark dose estimation in southern China.
    J Bone Miner Res. 2017 Apr 13. doi: 10.1002/jbmr.3151.
    PubMed     Text format     Abstract available


  175. MORRIS JA, Tsai PC, Joehanes R, Zheng J, et al
    Epigenome-wide association of DNA methylation in whole blood with bone mineral density.
    J Bone Miner Res. 2017 Apr 10. doi: 10.1002/jbmr.3148.
    PubMed     Text format     Abstract available


  176. HAMILL MM, Pettifor JM, Ward KA, Norris SA, et al
    Changes in Bone Mineral Density, Body Composition, Vitamin D Status and Mineral Metabolism in Urban HIV-positive South African Women Over 12 Months.
    J Bone Miner Res. 2017 Apr 1. doi: 10.1002/jbmr.3147.
    PubMed     Text format     Abstract available


    March 2017
  177. STOECKER WV, Carson A, Nguyen VH, Willis AB, et al
    Addressing the Crisis in the Treatment of Osteoporosis: Better Paths Forward.
    J Bone Miner Res. 2017 Mar 31. doi: 10.1002/jbmr.3145.
    PubMed     Text format     Abstract available


  178. WIEPJES CM, Vlot MC, Klaver M, Nota NM, et al
    Bone Mineral Density Increases in Trans Persons After One Year Hormonal Treatment: A Multicenter Prospective Observational Study.
    J Bone Miner Res. 2017 Mar 29. doi: 10.1002/jbmr.3102.
    PubMed     Text format     Abstract available


  179. LAWSON MA, Ebetino FH, Mazur A, Chantry AD, et al
    The Pharmacological Profile of a Novel Highly Potent Bisphosphonate, OX14 (1-fluoro-2-(imidazo-[1,2-alpha]pyridin-3-yl)ethyl-bisphosphonate.
    J Bone Miner Res. 2017 Mar 24. doi: 10.1002/jbmr.3138.
    PubMed     Text format     Abstract available


  180. NIELSON CM, Wiedrick J, Shen J, Jacobs J, et al
    Identification of Hip BMD Loss and Fracture Risk Markers through Population-based Serum Proteomics.
    J Bone Miner Res. 2017 Mar 18. doi: 10.1002/jbmr.3125.
    PubMed     Text format     Abstract available


  181. SCHOUSBOE JT, Vo TN, Langsetmo L, Taylor BC, et al
    Association of Trabecular Bone Score (TBS) with Incident Clinical and Radiographic Vertebral Fractures Adjusted for Lumbar Spine BMD in Older Men: A Prospective Cohort Study.
    J Bone Miner Res. 2017 Mar 16. doi: 10.1002/jbmr.3130.
    PubMed     Text format     Abstract available


  182. GREY A, Bolland M, Cundy T
    Maintaining Order in Osteoporosis Treatments.
    J Bone Miner Res. 2017 Mar 15. doi: 10.1002/jbmr.3127.
    PubMed     Text format     Abstract available


  183. OHLSSON C, Nethander M, Kindmark A, Ljunggren O, et al
    Low Serum DHEAS Predicts Increased Fracture Risk in Older Men - the MrOS Sweden Study.
    J Bone Miner Res. 2017 Mar 9. doi: 10.1002/jbmr.3123.
    PubMed     Text format     Abstract available


  184. MARQUES EA, Elbejjani M, Gudnason V, Sigurdsson G, et al
    Proximal Femur Volumetric Bone Mineral Density and Mortality: 13 Years of Follow-up of the AGES-Reykjavik Study.
    J Bone Miner Res. 2017 Mar 9. doi: 10.1002/jbmr.3104.
    PubMed     Text format     Abstract available


  185. SORNAY-RENDU E, Boutroy S, Duboeuf F, Chapurlat RD, et al
    Bone Microarchitecture Assessed by HR-pQCT as Predictor of Fracture Risk in Postmenopausal Women: The OFELY Study.
    J Bone Miner Res. 2017 Mar 9. doi: 10.1002/jbmr.3105.
    PubMed     Text format     Abstract available


  186. HIND K, Pearce M, Birrell F
    Total and Visceral Adiposity Are Associated With Prevalent Vertebral Fracture in Women But Not Men at Age 62 Years: The Newcastle Thousand Families Study.
    J Bone Miner Res. 2017 Mar 6. doi: 10.1002/jbmr.3085.
    PubMed     Text format     Abstract available


  187. KAESMACHER J, Schweizer C, Valentinitsch A, Baum T, et al
    Osteoporosis Is the Most Important Risk Factor for Odontoid Fractures in the Elderly.
    J Bone Miner Res. 2017 Mar 3. doi: 10.1002/jbmr.3120.
    PubMed     Text format     Abstract available


  188. TRAN T, Bliuc D, van Geel T, Adachi JD, et al
    Population-wide Impact of Non-hip Non-vertebral Fractures on Mortality.
    J Bone Miner Res. 2017 Mar 3. doi: 10.1002/jbmr.3118.
    PubMed     Text format     Abstract available


  189. YU EW, Lee MP, Landon JE, Lindeman KG, et al
    Fracture Risk After Bariatric Surgery: Roux-en-Y Gastric Bypass Versus Adjustable Gastric Banding.
    J Bone Miner Res. 2017 Mar 2. doi: 10.1002/jbmr.3101.
    PubMed     Text format     Abstract available


    February 2017
  190. BRUNO AG, Burkhart K, Allaire B, Anderson DE, et al
    Spinal Loading Patterns from Biomechanical Modeling Explain the High Incidence of Vertebral Fractures in the Thoracolumbar Region.
    J Bone Miner Res. 2017 Feb 27. doi: 10.1002/jbmr.3113.
    PubMed     Text format     Abstract available


  191. ANASTASILAKIS AD, Polyzos SA, Makras P, Aubry-Rozier B, et al
    Clinical Features of 24 Patients with Rebound-associated Vertebral Fractures Following Denosumab Discontinuation: Systematic Review and Additional Cases.
    J Bone Miner Res. 2017 Feb 27. doi: 10.1002/jbmr.3110.
    PubMed     Text format     Abstract available


  192. GILLESPIE CW, Morin PE
    Osteoporosis-Related Health Services Utilization Following First Hip Fracture Among a Cohort of Privately-Insured Women in the United States, 2008-2014: An Observational Study.
    J Bone Miner Res. 2017 Feb 23. doi: 10.1002/jbmr.3079.
    PubMed     Text format     Abstract available


  193. COHEN A, Kousteni S, Bisikirska B, Shah JG, et al
    IGF-1 Receptor Expression on Circulating Osteoblast Progenitor Cells Predicts Tissue-based Bone Formation Rate and Response to Teriparatide in Premenopausal Women with Idiopathic Osteoporosis.
    J Bone Miner Res. 2017 Feb 20. doi: 10.1002/jbmr.3109.
    PubMed     Text format     Abstract available


  194. CHESI A, Mitchell JA, Kalkwarf HJ, Bradfield JP, et al
    A Genome-Wide Association Study Identifies Two Sex-specific Loci, at SPTB and IZUMO3, Influencing Pediatric Bone Mineral Density at Multiple Skeletal Sites.
    J Bone Miner Res. 2017 Feb 9. doi: 10.1002/jbmr.3097.
    PubMed     Text format     Abstract available


  195. CAMPOS-OBANDO N, Koek WN, Hooker ER, van der Eerden BC, et al
    Serum Phosphate Is Associated with Fracture Risk: The Rotterdam Study and MrOS.
    J Bone Miner Res. 2017 Feb 8. doi: 10.1002/jbmr.3094.
    PubMed     Text format     Abstract available


    January 2017
  196. VERONESE N, Stubbs B, Crepaldi G, Solmi M, et al
    Relationship between Low Bone Mineral Density and Fractures with Incident Cardiovascular Disease: A Systematic Review and Meta-analysis.
    J Bone Miner Res. 2017 Jan 31. doi: 10.1002/jbmr.3089.
    PubMed     Text format     Abstract available


  197. WATTS NB, Aggers D, McCarthy EF, Savage T, et al
    Responses to Treatment with Teriparatide in Patients with Atypical Femur Fractures Previously Treated with Bisphosphonates.
    J Bone Miner Res. 2017 Jan 10. doi: 10.1002/jbmr.3081.
    PubMed     Text format     Abstract available


  198. WANG W, Wang H, Zhou X, Li X, et al
    Lymphatic Endothelial Cells Produce M-CSF Causing Massive Bone Loss in Mice.
    J Bone Miner Res. 2017 Jan 4. doi: 10.1002/jbmr.3077.
    PubMed     Text format     Abstract available


    December 2016
  199. KHOSLA S, Cauley JA, Compston J, Kiel DP, et al
    Addressing the Crisis in the Treatment of Osteoporosis: A Path Forward.
    J Bone Miner Res. 2016 Dec 29. doi: 10.1002/jbmr.3074.
    PubMed     Text format     Abstract available


  200. RAMOS-JUNIOR ES, Leite GA, Carmo-Silva CC, Taira TM, et al
    Adipokine Chemerin Bridges Metabolic Dyslipidemia and Alveolar Bone Loss in Mice.
    J Bone Miner Res. 2016 Dec 28. doi: 10.1002/jbmr.3072.
    PubMed     Text format     Abstract available


  201. NAGATA JM, Golden NH, Leonard MB, Copelovitch L, et al
    Assessment of Sex Differences in Fracture Risk among Patients with Anorexia Nervosa: A Population-Based Cohort Study using The Health Improvement Network.
    J Bone Miner Res. 2016 Dec 26. doi: 10.1002/jbmr.3068.
    PubMed     Text format     Abstract available


  202. ORCHARD T, Yildiz V, Steck SE, Hebert JR, et al
    Dietary Inflammatory Index, Bone Mineral Density and Risk of Fracture in Postmenopausal Women: Results from the Women's Health Initiative.
    J Bone Miner Res. 2016 Dec 26. doi: 10.1002/jbmr.3070.
    PubMed     Text format     Abstract available


  203. TREJO P, Fassier F, Glorieux FH, Rauch F, et al
    Diaphyseal Femur Fractures in Osteogenesis Imperfecta: Characteristics and Relationship with Bisphosphonate Treatment.
    J Bone Miner Res. 2016 Dec 26. doi: 10.1002/jbmr.3071.
    PubMed     Text format     Abstract available


  204. MALOUF-SIERRA J, Tarantino U, Garcia-Hernandez PA, Corradini C, et al
    Effect of Teriparatide or Risedronate in Elderly Patients with a Recent Pertrochanteric Hip Fracture: Final Results of a 78-Week Randomized Clinical Trial.
    J Bone Miner Res. 2016 Dec 26. doi: 10.1002/jbmr.3067.
    PubMed     Text format     Abstract available


  205. FINK HA, Vo TN, Langsetmo L, Barzilay JI, et al
    Association of Increased Urinary Albumin with Risk of Incident Clinical Fracture and Rate of Hip Bone Loss: The Osteoporotic Fractures in Men Study.
    J Bone Miner Res. 2016 Dec 24. doi: 10.1002/jbmr.3065.
    PubMed     Text format     Abstract available


  206. AHMAD OS, Leong A, Miller JA, Morris JA, et al
    A Mendelian Randomization Study of the Effect of Type-2 Diabetes and Glycemic Traits on Bone Mineral Density.
    J Bone Miner Res. 2016 Dec 16. doi: 10.1002/jbmr.3063.
    PubMed     Text format     Abstract available


  207. LANGSETMO L, Shikany JM, Cawthon PM, Cauley JA, et al
    The Association Between Protein Intake by Source and Osteoporotic Fracture in Older Men: A Prospective Cohort Study.
    J Bone Miner Res. 2016 Dec 12. doi: 10.1002/jbmr.3058.
    PubMed     Text format     Abstract available


  208. LI J, Wang Q, Yang R, Zhang J, et al
    BMI-1 Mediates Estrogen-Deficiency-Induced Bone Loss by Inhibiting Reactive Oxygen Species Accumulation and T Cell Activation.
    J Bone Miner Res. 2016 Dec 12. doi: 10.1002/jbmr.3059.
    PubMed     Text format     Abstract available


  209. COSMAN F, Nieves JW, Dempster D
    Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis.
    J Bone Miner Res. 2016 Dec 7. doi: 10.1002/jbmr.3051.
    PubMed     Text format     Abstract available


  210. KO FC, Karim L, Brooks DJ, Bouxsein ML, et al
    Bisphosphonate Withdrawal: Effects on Bone Formation and Bone Resorption in Maturing Male Mice.
    J Bone Miner Res. 2016 Dec 7. doi: 10.1002/jbmr.3052.
    PubMed     Text format     Abstract available


    November 2016
  211. CUMMINGS SR, Cosman F, Lewiecki EM, Schousboe JT, et al
    Goal-Directed Treatment for Osteoporosis: A Progress Report from the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis.
    J Bone Miner Res. 2016 Nov 19. doi: 10.1002/jbmr.3039.
    PubMed     Text format     Abstract available


  212. YANG S, Leslie WD, Walld R, Roos LL, et al
    Objectively-Verified Parental Non-Hip Major Osteoporotic Fractures and Offspring Osteoporotic Fracture Risk: A Population-Based Familial Linkage Study.
    J Bone Miner Res. 2016 Nov 10. doi: 10.1002/jbmr.3035.
    PubMed     Text format     Abstract available


  213. WU VC, Chang CH, Wang CY, Lin YH, et al
    Risk of Fracture in Primary Aldosteronism: A Population-Based Cohort Study.
    J Bone Miner Res. 2016 Nov 10. doi: 10.1002/jbmr.3033.
    PubMed     Text format     Abstract available


  214. TOBIAS JH, Gregson CL
    Genetic Studies of Endophenotypes From Spine CT Scans Provide Novel Insights Into the Contribution of Mechanosensory Pathways to Vertebral Fractures and Spinal Curvature.
    J Bone Miner Res. 2016 Nov 9. doi: 10.1002/jbmr.3032.
    PubMed     Text format    


  215. TAN EM, Li L, Indran IR, Chew N, et al
    TRAF6 mediates suppression of osteoclastogenesis and prevention of ovariectomy-induced bone loss by a novel prenylflavonoid.
    J Bone Miner Res. 2016 Nov 4. doi: 10.1002/jbmr.3031.
    PubMed     Text format     Abstract available


    October 2016
  216. ORWOLL ES, Lapidus J, Wang PY, Vandenput L, et al
    The limited clinical utility of testosterone, estradiol and sex hormone binding globulin measurements in the prediction of fracture risk and bone loss in older men.
    J Bone Miner Res. 2016 Oct 18. doi: 10.1002/jbmr.3021.
    PubMed     Text format     Abstract available


  217. CHOI NK, Solomon DH, Tsacogianis TN, Landon JE, et al
    Comparative Safety and Effectiveness of Denosumab Versus Zoledronic Acid in Patients With Osteoporosis: A Cohort Study.
    J Bone Miner Res. 2016 Oct 13. doi: 10.1002/jbmr.3019.
    PubMed     Text format     Abstract available


  218. SCOTT D, Seibel M, Cumming R, Naganathan V, et al
    Sarcopenic Obesity and its Temporal Associations with Changes in Bone Mineral Density, Incident Falls and Fractures in Older Men: The Concord Health and Ageing in Men Project.
    J Bone Miner Res. 2016 Oct 13. doi: 10.1002/jbmr.3016.
    PubMed     Text format     Abstract available


  219. KIM HY, Kim JW, Kim SJ, Lee SH, et al
    Uncertainty of Current Algorithm for Bisphosphonate-related Osteonecrosis of the Jaw in Population-based Studies: A Systematic Review.
    J Bone Miner Res. 2016 Oct 13. doi: 10.1002/jbmr.3017.
    PubMed     Text format     Abstract available


  220. SCHEM C, Tower RJ, Kneissl P, Rambow AC, et al
    Pharmacologically Inactive Bisphosphonates as an Alternative Strategy for Targeting Osteoclasts: In Vivo Assessment of 5-Fluorodeoxyuridine-Alendronate in a Preclinical Model of Breast Cancer Bone Metastases.
    J Bone Miner Res. 2016 Oct 7. doi: 10.1002/jbmr.3012.
    PubMed     Text format     Abstract available


  221. JIN C, Zhang P, Zhang M, Zhang X, et al
    Inhibition of SLC7A11 by sulfasalazine enhances osteogenic differentiation of mesenchymal stem cells by modulating BMP2/4 expression and suppresses bone loss in ovariectomized mice.
    J Bone Miner Res. 2016 Oct 3. doi: 10.1002/jbmr.3009.
    PubMed     Text format     Abstract available


  222. ADLER RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, et al
    Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.
    J Bone Miner Res. 2016;31:1910.
    PubMed     Text format    


    September 2016
  223. MAJOOR BC, Appelman-Dijkstra NM, Fiocco M, van de Sande MA, et al
    Outcome of Long-Term Bisphosphonate Therapy in McCune-Albright Syndrome and Polyostotic Fibrous Dysplasia.
    J Bone Miner Res. 2016 Sep 20. doi: 10.1002/jbmr.2999.
    PubMed     Text format     Abstract available


  224. HO-LE TP, Center JR, Eisman JA, Nguyen HT, et al
    Prediction of Bone Mineral Density and Fragility Fracture by Genetic Profiling.
    J Bone Miner Res. 2016 Sep 20. doi: 10.1002/jbmr.2998.
    PubMed     Text format     Abstract available


  225. CHANDRA A, Lin T, Young T, Tong W, et al
    Suppression of Sclerostin Alleviates Radiation-Induced Bone Loss by Protecting Bone Forming Cells and Their Progenitors through Distinct Mechanisms.
    J Bone Miner Res. 2016 Sep 16. doi: 10.1002/jbmr.2996.
    PubMed     Text format     Abstract available


  226. COSMAN F, Hattersley G, Hu MY, Williams GC, et al
    Effects of Abaloparatide-SC on Fractures and Bone Mineral Density in Subgroups of Postmenopausal Women with Osteoporosis and Varying Baseline Risk Factors.
    J Bone Miner Res. 2016 Sep 9. doi: 10.1002/jbmr.2991.
    PubMed     Text format     Abstract available


    March 2016
  227. KHAN MP, Singh AK, Singh AK, Shrivastava P, et al
    Odanacatib Restores Trabecular Bone of Skeletally Mature Female Rabbits With Osteopenia but Induces Brittleness of Cortical Bone: A Comparative Study of the Investigational Drug With PTH, Estrogen, and Alendronate.
    J Bone Miner Res. 2016;31:615-29.
    PubMed     Text format     Abstract available


    February 2016
  228. ZHANG P, Liu Y, Jin C, Zhang M, et al
    Histone Acetyltransferase GCN5 Regulates Osteogenic Differentiation of Mesenchymal Stem Cells by Inhibiting NF-kappaB.
    J Bone Miner Res. 2016;31:391-402.
    PubMed     Text format     Abstract available


  229. ZHANG X, Hamadeh IS, Song S, Katz J, et al
    Osteonecrosis of the Jaw in the United States Food and Drug Administration's Adverse Event Reporting System (FAERS).
    J Bone Miner Res. 2016;31:336-40.
    PubMed     Text format     Abstract available


  230. ASHPOLE NM, Herron JC, Mitschelen MC, Farley JA, et al
    IGF-1 Regulates Vertebral Bone Aging Through Sex-Specific and Time-Dependent Mechanisms.
    J Bone Miner Res. 2016;31:443-54.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: